On August 28, Synopsys declined 3.18% in regular trading, trading at approximately 450.7 USD/share, with turnover of $42.95 million. The stock opened sharply higher, touching an intraday high of $458.59 before succumbing to selling pressure.

On the news front, Baird upgraded Synopsys to outperform with a $560 price target, citing strong FY2027 prospects after a transitional year, which initially drove shares up roughly 13%. However, Mizuho simultaneously lowered its target price from $600 to $550, dampening bullish momentum. The conflicting analyst signals, combined with aggressive profit-taking following the sharp gap-up, triggered the reversal.

The pullback also reflects lingering concerns over growth sustainability. While Q3 results significantly beat expectations — adjusted EPS of $3.91 versus the $3.67 consensus, and revenue of $2.48 billion representing 42% year-over-year growth — the full-year revenue guidance of $9.69-$9.74 billion only marginally exceeded the $9.68 billion consensus, prompting a sell-the-news reaction as investors questioned the pace of forward growth.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)